Page last updated: 2024-10-21

enprofylline and Asthmatic Crisis

enprofylline has been researched along with Asthmatic Crisis in 1 studies

enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.

Research Excerpts

ExcerptRelevanceReference
"Five different doses of enprofylline, a 3-propylxanthine, were compared with a standard dose of theophylline in 135 episodes of acute asthma in a double-blind study."9.06Efficacy of enprofylline, a new bronchodilating xanthine, in acute asthma. ( Boe, J; Eriksson, G; Ljungholm, K, 1987)
"Five different doses of enprofylline, a 3-propylxanthine, were compared with a standard dose of theophylline in 135 episodes of acute asthma in a double-blind study."5.06Efficacy of enprofylline, a new bronchodilating xanthine, in acute asthma. ( Boe, J; Eriksson, G; Ljungholm, K, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boe, J1
Eriksson, G1
Ljungholm, K1

Trials

1 trial available for enprofylline and Asthmatic Crisis

ArticleYear
Efficacy of enprofylline, a new bronchodilating xanthine, in acute asthma.
    Annals of allergy, 1987, Volume: 59, Issue:2

    Topics: Adult; Aged; Asthma; Blood Pressure; Bronchodilator Agents; Female; Heart Rate; Humans; Male; Middle

1987